- ifip-tc6 - lists.rwth-aachen.de

TC6 publications
by Otto Spaniol 18 Nov '04

18 Nov '04

Dear all (+ Wojtek Cellary, organisor of I3E), I just phoned Alfred Hofmann from Springer (for I3E and for another non-IFIP event) and got the following maybe important information: There are two possibilities for IFIP publications: - "old style KAP" (Kluwer Academic Publisher) - Springer LNCS. Apparently there is heavy competition between those two possibilities inside the newly merged Kluwer-Springer. It is strongly recommended by Alfred Hofmann to use LNCS instead as of old-style KAP. The reasons: - LNCS is much cheaper (in the bookstore) than old-style KAP, just 35 percent of old-style KAP; it is soft-cover instad as of hard-cover but for only a third of the price this appears to be more than tolerable. - LNCS is included in digital library, old-style KAP is not. - The organisor doesn't have to make a certain bulk size at his own risk, he can order as many copies as he wants. - The organisor gets 50 copies for free, thus for some small workshops he will not have to pay a single cent for the proceedings; the Springer revenue out of LNCS comes from the much higher sales numbers due to the much cheaper price. Thus Springer can afford to give 50 copies for free. - As an example, Alfred told me that INTERACT took 450 books with 850 pages each. The cost with old-style KAP would have been 63.000 EURO (or maybe dollar, I don't remember perfectly) but with LNCS it was not more than 19.000 EURO (or dollar). Thus LNCS publication is very strongly recommended. The only condition is that a very thorough and strong reviewing will be effected. I urge all of our WG chairs that they invite many organisors to seriously check the LNCS possibility. Alfred told me that some other TC's have already taken this as the standard way for publishing IFIP event proceedings. Alfred's phone number is in the list of IFIP delegates: +49-6221-4878599 Hofmann(a)Springer.de Yana Lambert (from old-style KAP) will not be delighted to see that comparison but she will have to live with it. Best regards Otto

2 1

re:[ifip-tc6] TC6 publications
by Ramon Puigjaner 18 Nov '04

18 Nov '04

Dear Otto, Thank you very much for this information. It will be very useful for the conferences organised in developing countries. This point, in Toulouse during the GA, remain in the dark space, even that several question appear to know these aspects, but Jennifer Evans (Yana Lambert was sick) skipped to answer. Best regards Ramon > Dear all (+ Wojtek Cellary, organisor of I3E), > > I just phoned Alfred Hofmann from Springer (for I3E and for another > non-IFIP event) and got the following maybe important information: > > There are two possibilities for IFIP publications: > - "old style KAP" (Kluwer Academic Publisher) > - Springer LNCS. > > Apparently there is heavy competition between those two possibilities > inside the newly merged Kluwer-Springer. > > It is strongly recommended by Alfred Hofmann to use LNCS instead as > of old-style KAP. > > The reasons: > - LNCS is much cheaper (in the bookstore) than old-style KAP, > just 35 percent of old-style KAP; > it is soft-cover instad as of hard-cover but for only a third of > the price this appears to be more than tolerable. > - LNCS is included in digital library, old-style KAP is not. > - The organisor doesn't have to make a certain bulk size at his own risk, > he can order as many copies as he wants. > - The organisor gets 50 copies for free, thus for some small workshops > he will not have to pay a single cent for the proceedings; > the Springer revenue out of LNCS comes from the much higher > sales numbers due to the much cheaper price. Thus Springer can afford > to give 50 copies for free. > - As an example, Alfred told me that INTERACT took 450 books with > 850 pages each. The cost with old-style KAP would have been > 63.000 EURO (or maybe dollar, I don't remember perfectly) > but with LNCS it was not more than 19.000 EURO (or dollar). > > Thus LNCS publication is very strongly recommended. > The only condition is that a very thorough and strong reviewing > will be effected. > I urge all of our WG chairs that they invite many organisors > to seriously check the LNCS possibility. Alfred told me that some other > TC's have already taken this as the standard way for publishing > IFIP event proceedings. > > Alfred's phone number is in the list of IFIP delegates: +49-6221-4878599 > Hofmann(a)Springer.de > > Yana Lambert (from old-style KAP) will not be delighted to see that > comparison but she will have to live with it. > > Best regards > Otto > > > > > _______________________________________________ > ifip-tc6 mailing list > ifip-tc6(a)lists.RWTH-Aachen.DE > http://MailMan.RWTH-Aachen.DE/mailman/listinfo/ifip-tc6 > ========================================================================= Ramon Puigjaner Universitat de les Illes Balears Departament de Ciencies Matematiques i Informatica 07122 PALMA (Spain) Phone: +34-971173288 Fax: +34-971173003 e-mail: putxi(a)uib.es =========================================================================

1 0

Updated attendance list
by Otto Spaniol 18 Nov '04

18 Nov '04

Dear all, please find enclosed the updated attendance list for meeting 2004/2. Would the three delegates who didn't send any message (i.e. delegates from Greece, Slovenia, and Syria) please give at least one line of code concerning their presence or - what appears to be much more likely - their non-attendance. If I don't get at least this minimum message then I intend to ask IFIP GA for a replacement very soon - since that form of missing activity cannot be tolerated any longer. Best regards Otto

1 0

Rien ne va plus...
by Otto Spaniol 18 Nov '04

18 Nov '04

Dear all, rien ne va plus ... concernant les contributions pour les documents de la réunion TC6 2004/2 à Bangkok. Vous pourriez adresser les choses les plus importantes (s'il y en aurait cettes choses) à Chutiporn Anutariya <chutiporn(a)shinawatra.ac.th>. Cordialement Otto

4 4

Re: [ifip-tc6] WCC 2006
by Ramon Puigjaner 18 Nov '04

18 Nov '04

Lyman and all others that have sent their opinion, Thank you very much for communicating your opinon in favour and against the participation of TC6 in WCC and, in consequence, of my acceptation of becoming TPC chair of WCC. Best regards Ramon > Ramon, > > As you know, my feeling is that the WCC is indeed a "dinosaur," and > it would be a waste of your time to chair the TPC. You are already > involved in many other events and activities that are much more > important and much more relevant than WCC! Similarly, I do not think > that TC6 should spend any time or energy on WCC. > > - Lyman > > At 4:35 AM +0100 11/16/04, Ramon Puigjaner wrote: > >Dear friends, > > > >All of you have received the message of Klaus Brunnstein, President of > >IFIP. In this message I appear when he is talking about WCC. > > > >You should know that he has asked me to chair the TPC of this event. > >Personally I do not know if the effort of well organising such a > >"dinosaur", like the last one in Toulouse, is compensated by its results > >both in scientific and personal exchanges aspects. However, my personal > >involvement in Latin America actions obliges me to carefully consider > >the proposal. > > > >After talking with Otto Spaniol, our chairman, my position is to accept > >the proposal only if I have a strong support of TC6 both by the > >organisation of some events in the next WCC and by the personal > >involvement of TC6 members in the TPC. Otherwise I will be obliged to > >withdraw the proposal. > > > >As this last time the electronic discussions are one of our main duties, > >I would like to know your position, before or during our next meeting in > >order to give me the inputs to take the correct decision. > > > >I wish to thank you in advance your help in clarifying my ideas. > > > >Best regards > > > >Ramon > >========================================================================= > >Ramon Puigjaner > >Universitat de les Illes Balears > >Departament de Ciencies Matematiques i Informatica > >07122 PALMA (Spain) > >Phone: +34-971173288 Fax: +34-971173003 > >e-mail: putxi(a)uib.es > >========================================================================= ========================================================================= Ramon Puigjaner Universitat de les Illes Balears Departament de Ciencies Matematiques i Informatica 07122 PALMA (Spain) Phone: +34-971173288 Fax: +34-971173003 e-mail: putxi(a)uib.es =========================================================================

3 2

Re: [ifip-tc6] Rien ne va plus...
by Lyman Chapin 18 Nov '04

18 Nov '04

1 0

Shrinking attendance
by Otto Spaniol 18 Nov '04

18 Nov '04

Dearr all, our meeting 2004/2 attendance is shrinking; just 14 delegates are left (if they all show up). Please communicate to me your view on the IFIP/IEEE case. Answers received thus far may be classified in two parts: - The Americans are in favour of IEEE (the copyright issue seems to be of no impoortance for them, at least nbody has said a single word about that aspect) - The Americans are more on the IFIP side. They say e.g. "Do you think that there should be only one organisation world-wide? There is need for more".

2 1

Tissue Engineering & Stem Cell Research 2005
by Andrew Oliver 16 Nov '04

16 Nov '04

============================================ Tissue Engineering & Stem Cell Research 2005 12th and 13th January 2005 Marriot Kensington Hotel, London ============================================ **** CONFERENCE BROCHURE AVAILABLE NOW - REQUEST YOURS TODAY **** Visiongain Conferences are please to announce their next conference within the pharmaceutical sector; 'Tissue Engineering & Stem Cell Research 2005'. Stem cell therapy offers an opportunity to treat many degenerative diseases caused by the premature death or malfunction of specific cell types and the body's failure to replace or restore them. This conference will cover the main disease areas where progress in stem cell research is taking place along with a huge emphasis on regional regulatory issues. THEMES WILL INCLUDE: **Identify new routes to enter the market **Discover key market segments and profit from emerging trends in stem cell therapies **An update on stem cell therapies: CASE STUDIES on treating- spinal cord injuries, kidney disease, gastrointestinal cancers, neurological diseases, myocardial and tooth regeneration **Analyse manufacturing practices and learn how to overcome the challenges in tissue engineering **Become up-to-date on regulatory issues: a global and US perspective **Business Development: commercialisation for drug discovery and cell therapy KEY SPEAKERS **Dr. Jane Lebkowski, Senior Vice President, Regenerative Medicine, Geron **Julie Gruber Allickson, Technical Director - Laboratory Operations, Cryo-Cell International **Dr. Stephen Minger, Scientific Director/ Director of the Stem Cell Biology Laboratory, CereStem Ltd/ KCL **Dr. Christopher Bravery, Senior Scientist/Team Leader, Intercytex Limited **Larry Soler, Vice President of Government Relations, Juvenile Diabetes Research Foundation International **Dr. Sara Patel, Head of NeuroImaging Group, ReNeuron **Dr. Karl Willert, Postdoctoral fellow, Stanford University Medical Center **Dr Phil Bates, Lecturer in Medical Law, Centre for Medical Law and Ethics, Kings College London **Dr Chris Potten, Chairman, Epistem **David Hill, Scientific Director, Lawson Health Research Institute **Dr. Lior Gepstein, Head Cardiovascular Research Laboratory, Technion-Israel Institute of Technology **Professor Paul Sharpe, Head of Craniofacial Development, Odontis Ltd / King's College London **Professor Jon Dobson,Professor of Biophysics & Biomedical Engineering , Keele University **Professor Alicia El Haj, Institute of Science & Technology in Medicine, Keele University **Dr. Richard France, Project Manager, RegenTec Ltd **Professor Harry Moore, Director/ Centre for Stem Cell Biology, Axordia/ University of Sheffield ------------------ WHO SHOULD ATTEND ------------------ **Senior Vice President, Regenerative Medicine **Research Director for Assisted Reproduction and Embryonic Stem Cells **Vice President, Technology **Vice President, Therapeutic Development Operations **Director, Experimental Medicine **Vice President of Government Relations **Vice President Clinical Affairs, & Director **Vice President, Product Development **Business Development Manager --------------------- DELEGATE REGISTRATION --------------------- Places at this event are strictly limited so BOOK YOUR PLACE NOW. To make a booking on this event, please contact me via phone or email. Book early to secure a place. - PRICING - Attend the: 2 Day conference - ONLY GBP1299 plus VAT - BOOKINGS - Booking is easy, simply contact me: Andrew Oliver Sales Manager - Conference Division Visiongain B2B Conferences Tel. +44(0)20 8767 6711 Fax. +44(0)20 8767 5001 mailto:andrew.oliver@visiongaingroup.com www.b2b-conferences.com B2B Conferences is part of the Visiongain Group **** FULL CONFERENCE AGENDA BELOW **** ==================================== Day One Wednesday 12th January 2005 ==================================== 09:00 Registration and coffee 09:30 Opening remarks from the chair AN UPDATE ON STEM CELL THERAPIES 09:40 CASE STUDY: Advances in Stem Cell Programs- Treating Spinal Cord Injuries How to penetrate the emerging field of regenerative medicine Oligodendrocyte progenitors- can they restore normal neural function? - results in animal models: significant functional improvements Progress in phase I clinical trials: focus on treatment for acute spinal cord injury Technologies in this field- licenses and intellectual property Dr. Jane Lebkowski, Senior Vice President, Regenerative Medicine Geron 10:20 CASE STUDY: Metanephroi Transplantation- Treating Kidney Disease How to develop normal renal structures by transplanting kidney precursors Transplanting between species without rejection- how to ensure minimal immunosupression, leading to success Conclusions: implanted metanephroi have intrinsic ability to continue developing and organising into functional tissue structures Advantages over renal transplant or dialysis: - better clinical outcome than intermittent dialysis, as filtration is continuous and active - unlimited supply of organs available by this procedure Dr. Christopher Bravery, Senior Scientist/Team Leader Intercytex Limited 11:00 Morning Coffee 11:20 CASE STUDY: in vitro and in vivo Model Systems- Treating Gastrointestinal Cancers in vivo models: using the in situ tumour model ADENOQUANT to directly compare tumour and normal tissue responses and assess therapeutic index Transgenic and xenograft models: how to determine the importance of gene pathways and treatment response in GI tissue in vitro screening assay: PRIMEQUANT to realistically predict the in vivo response and allow accurate comparisons of normal and matched tumour tissue biology How to use assays to assess stem cell regulatory effects to hyper- and hypoplasia therapies, wound healing agents and mucositis therapies Professor Chris Potten, Chairman Epistem 12:00 CASE STUDY: Development of islets from precursor cells in vitro and in vivo Generation of insulin-producing cells from embryonic stem cells or hematopoeitic stem cells Trans-differentiation capabilities of other pancreatic cell types to islets Barriers to clinical application Mechanisms of regeneration of islets in vivo David Hill, Scientific Director Lawson Health Research Institute 12:40 Lunch 14:00 Can Human Brain Cell Transplantation treat Neurological Diseases? Assess advantages and disadvantages of immortalised stem cell lines c-Myc gene cell lines: transplant strategies Graft effects in animal models of neurodegenerative diseasefunctional and structural integration How to use stem cells as a platform technology for drug discovery - identifying small molecules or proteins to mature a brain stem cell into a differentiated cell - stem cells for screening potential lead compounds for toxicity Dr. Sara Patel, Head of NeuroImaging Group ReNeuron 14:40 Myocardial Regeneration Strategies using Human Embryonic Stem Cells Heart cells from human embryonic stem cells- progress to date - derivation, in vitro differentiation and implications for basic research & clinical applications How to use it- development and testing of new drugs, genetic studies, engineering tissues, organ transplantation, study purposes Myocardial regeneration strategies- replacing the dysfunctional myocardium with new contractile tissue Regulations in Israel- looking to the future in research Dr. Lior Gepstein, Head Cardiovascular Research Laboratory Technion-Israel Institute of Technology 15:20 Afternoon Tea 15:40 CASE STUDY: Regenerative Dentistry- How to Grow a Tooth How to understand and genetically control the key processes forming teeth in the embryo Interactions between epithelial and mesenchymal cells - how to culture cells to form primordia Results from mice populations- tooth rudiments formed from in vitro cultures of non-dental stem cell populations Can rudiments be transferred to adults? - formation of complete teeth and associated bones Professor Paul Sharpe, Head of Craniofacial Development Odontis Ltd / King's College London MANUFACTURING PRACTICES: CHALLENGES IN TISSUE ENGINEERING 16:20 Implications of GTP/GMP for Cord Blood Processing Moving from Clean Lab to an ISO class 7 Cleanroom Environment How the FDA's proposed GTP affects cell processing Future Direction: cord blood processing - regulatory impacts Julie Gruber Allickson, Technical Director - Laboratory Operations Cryo-Cell International 17:00 Questions and Discussion 17:10 Chairman Summation 17:20 Close of Conference =================================== Day Two Thursday 13th January 2005 =================================== 09:00 Registration and coffee 09:30 Opening remarks from the chair An Overview of the Industry The panel session at the end of Day Two will offer you the chance to hear from Ray Scraggs, Head Consultant at visiongain on the most detailed and accurate market information available on Tissue Engineering and Stem Cell Research. 09:40 Advances in Tissue Regeneration: Human ES Cells, Growth Factors and Biotherapeutic Molecules The sources of stem cell and ES cells- learn about the benefits of stem cell technology Cell nuclear replacement: the fight against type 1 diabetes and Parkinson's disease Exploiting novel growth factors: promoting the proliferation and lineage-specific propagation of stem cell populations Dr. Stephen Minger, Scientific Director/ Director of the Stem Cell Biology Laboratory CereStem Ltd/ King's College London 10:20 Magnecell's Mechanical Conditioning Bioreactor Systems: How to Activate Ion Channels Update on ex-vivo bone engineering results - speed of matrix mineralisation; regulation of genes involved in bone growth Patent technologies for tissue engineering: mechanisms for ex-vivo simulation of the in-vivo stress environment Applications of system: drug screening, in-vitro testing and stem cell research Future areas for growth: ex-vivo magnetic activation of in-vivo cellular processes Professor Jon Dobson, Professor of Biophysics & Biomedical Engineering/ Co-Founder and Technical Advisor Keele University/ Magnecell Limited 11:00 Morning Coffee 11:20 Biodegradable scaffolds - Delivery systems for Cell Therapies Osteochondral and corneal repair using cell therapies and tissue engineering approaches Delivery vehicles and biodegradable scaffolds for cell therapies Scaffold design and in vitro and in vivo tissue engineering strategies Stem Cell targeting Professor Alicia El Haj, Institute of Science & Technology in Medicine Keele University 12:00 Self Assembling and Injectable Materials for Regenerative Medicine Injectable biodegradable scaffolds for cell and growth factor delivery Crosslinking strategies for scaffold self assembly Controlling macroporosity within the scaffold environment Dr. Richard France, Project Manager RegenTec Ltd 12:40 Lunch 14:00 Stem Cell Maintenance: Results from Isolating the Wnts Protein Potential of isolating Wnt proteins- can stem cells be used for bone marrow transplants? Wnt signaling: a common theme in animal development How do Wnt proteins cause hematopoietic stem cells to divide? Analysis: pathways triggering stem cell growth Dr. Karl Willert, Postdoctoral Fellow Stanford University Medical Center REGULATORY ISSUES 14:40 Global Perspective: Legal Framework for Stem Cell Research Global situation: US Federal ban on all bar 60 stem cell lineseffects on federally-funded research and privately funded research What is the legal framework for research in the UK? Lack of a co-ordinated global policy: effects on research Better results from stem cells derived from bone marrow and the placenta than embryonic stem cells Dr Phil Bates, Lecturer in Medical Law Centre for Medical Law and Ethics Kings College London 15:20 Afternoon Tea 15:40 Regulation in the US: Expanding the Current Federal Policy on Stem Cell Research The "Stem Cell Research Enhancement Act of 2004" Problems with the existing policy and proposed changes to overcome them Is adult stem cell research a feasible alternative? California's Proposition 71- update on progress Slowing down research- JDRF perspective Larry Soler, Vice President of Government Relations Juvenile Diabetes Research Foundation International BUSINESS DEVELOPMENT 16:20 Human Embryonic Stem Cells: Commercialisation for Drug Discovery and Cell Therapy Cell lines and quality assurance the challenge of generating GMP ES cell lines Regulating proliferation and plurioptency Markers of differentiation Production platforms Professor Harry Moore, Director/ Centre for Stem Cell Biology Axordia/ University of Sheffield 17:00 Discussion: Attendees Perspective Presentation and discussion by Dr. Ray Scraggs of the previous days questionnaire results. An insight will be given into the market revenues, growth areas, new developments and new entrants to the Tissue Engineering and Stem Cell Research industry. This will involve some freeform discussion giving you the opportunity to engage in knowledge-sharing with fellow professionals Moderator: Dr. Ray Scraggs, Head Consultant visiongain Consultancy 17:20 Question and Discussion 17:30 Chairman Summation 17:30 Close of Conference Terms & Conditions NB - Due to high demand, we do not 'reserve' or 'hold' places - a request for an invoice to be raised will be treated as an official booking and will be subject to the cancellation policy as outlined below. Cancellations/substitutions and name changes: All bookings carry a 50% liability after the booking has been made, by post fax, email or web. There will be no refunds for cancellations received on or after one month before the start of the conference (e.g. cancellation on or after 20th January for a conference starting on 20th February). If you decide to cancel after this date the full invoice remains payable. Conference notes, which are available on the day, will be sent to you. Unfortunately we are not able to transfer places between conferences and executive briefings. However if you are unable to attend the event you may make a substitution/name change at any time as long as we are informed in writing by e-mail, fax or post. Name changes and substitutions must be from the same company and are not transferable between companies or countries. Indemnity: visiongain Ltd reserve the right to change the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled due to acts of terrorism, war, extreme weather conditions, industrial action, acts of God or any event beyond the control of visiongain Ltd. If such a situation arises we will endeavour to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or cancelled. We therefore strongly advise all customers to take out insurance to cover the cost of the registration, travel and expenses. To unsubscribe please reply with unsubscribe in the subject line. Data protection: Visiongain Ltd gathers and manages data in accordance with the Data Protection Act 1998. Information contained about you may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. If you wish your details to be amended, please send your request to the Database Manager, visiongain Ltd, 40 Tooting High Street, London, SW17 0RG. Alternatively please reply with unsubscribe in the subject line. Please allow approximately 7 days for your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes come into effect.

1 0

WCC 2006
by Ramon Puigjaner 16 Nov '04

16 Nov '04

Dear friends, All of you have received the message of Klaus Brunnstein, President of IFIP. In this message I appear when he is talking about WCC. You should know that he has asked me to chair the TPC of this event. Personally I do not know if the effort of well organising such a “dinosaur”, like the last one in Toulouse, is compensated by its results both in scientific and personal exchanges aspects. However, my personal involvement in Latin America actions obliges me to carefully consider the proposal. After talking with Otto Spaniol, our chairman, my position is to accept the proposal only if I have a strong support of TC6 both by the organisation of some events in the next WCC and by the personal involvement of TC6 members in the TPC. Otherwise I will be obliged to withdraw the proposal. As this last time the electronic discussions are one of our main duties, I would like to know your position, before or during our next meeting in order to give me the inputs to take the correct decision. I wish to thank you in advance your help in clarifying my ideas. Best regards Ramon ========================================================================= Ramon Puigjaner Universitat de les Illes Balears Departament de Ciencies Matematiques i Informatica 07122 PALMA (Spain) Phone: +34-971173288 Fax: +34-971173003 e-mail: putxi(a)uib.es =========================================================================

3 2

MED-HOC-NET 2005
by Otto Spaniol 16 Nov '04

16 Nov '04

4th Mediterranean Workshop on Ad-Hoc Networks MED-HOC-NET 2005 Ile de Porquerolles, June 21-24, 2005 First Call for papers The fourth Med-Hoc-Net 2005 is a major annual international workshop in the Mediterrnean region. It brings together researchers, technologists and visionaries from academia, research labs, and industry, engineers and students to exchange, discuss and share their experiences, new ideas and research about theoretical and practical aspects of ad-hoc networking. Med-Hoc-Net 2005 will include presentations of theoretical and experimental achievements, innovative ad-hoc systems, prototyping efforts, case studies, and advancements in technology directly affecting ad-hoc networking and communications infrastructures. The papers solicited in Med-Hoc-Net 2005 cover a variety of topics including but not limited to: - Implementations, testbeds, and prototypes, - Performance evaluation of ad-hoc network protocols through simulations, analysis, and measurements, - Metrology, Ad-Hoc network measurement Tools, - MAC protocols, scheduling, and radio resource sharing in ad hoc networks, - Power management and control, - Topology control, - Self-organization and network reconfiguration, - Unicast and multicast routing algorithms and protocols, - Energy-efficient communications in ad-hoc networks, - Transport layer protocols for multi-hop networks, - Resource discovery and management, - Protocols for QoS support in ad-hoc networks, - Call admission and traffic shaping policies for ad-hoc networks, - Multimedia location services, - Security in ad-hoc networks, - Fault tolerance and error recovery - Algorithmic challenges in ad-hoc networks, - Large scale ad-hoc networks , - Interconnection between ad hoc and wired networks, - Sensor networks: applications and protocols. After Sardinia (Italy), Mahdia (Tunisia) and Bodrum (Turkey), this year the workshop will take place in another beautiful spot on the Mediterranean Sea: Ile de Porquerolles (France). Steering Committee: Farouk Kamoun (ENSI, Tunisia) Mario Gerla (UCLA, USA) Guy Pujolle (LIP6, France) Khaldoun Al Agha (LRI, France) Giovanni Pau (UCLA, USA) Conference Chairs: Khaldoun Al Agha (LRI, University of Paris XI) and Guy Pujolle (LIP6, University of Paris VI) Program Chair: Isabelle Guérin Lassous (INRIA, France) Proceedings chair : Erwan ERMEL (LIP6/France) Organization Chair :Davor MALES (LIP6, France) Webmaster : GAWDESKI Ignacy (LRI, France) Program Committee: Ian F. AKYILDIZ (Georgia Institute of Technology, USA) Khaldoun AL AGHA (LRI, France) Christian BECKER (University of Stuttgart, Germany) Brahim BENSAOU (Hong Kong University of science and technology, Hong Kong) Andrew T. CAMPBELL (Columbia University, USA) E. CAYIRCI (Istanbul Technical University, Turkey) Andrea CLEMENTI (University Roma II, Italy) Marco CONTI (CNR, Italy) Silvia GIORDANO (University of Applied Science, Switzerland) Stephen HAILES (University College London, United Kingdom) Farouk KAMOUN (ENSI, Tunisia) P. R. KUMAR (University of Illinois, Urbana-Champaign, USA) Pascale MINET (INRIA, France) Sotiris NIKOLETSEAS (CTI/Univ. of Patras, Greece) Giovanni PAU (UCLA, USA) Guy PUJOLLE (LIP6, France) Laurent REYNAUD (FT R&D, France) Christian PREHOFER (DoCoMo Euro-Labs, Germany) David SYMPLOT-RYL (University of Lille, France) Isabela SIQUEIRA (Federal University of Minas Gerais, Brazil) Stavros TOUMPIS ( Vienna Telecommunications Research Center, Austria) Christian TSCHUDIN (University of Basel, Switzerland) Guillaume VIVIER (Motorola, France) Stefan WEBER (Trinity College Dublin, Ireland) Vincent W.S. WONG (University of British Columbia, Canada) Hiroyuki YOMO (Aalborg University, Danemark) Authors are invited to submit electronically original contributions in the conference themes and related topics. Papers should not be longer than 12 pages. All submitted papers will be reviewed and evaluated on the basis of relevance, originality, technical quality and clarity. Accepted papers will be included in the conference proceedings. The official workshop oral and written language is English. Paper Submission Deadlines Full Paper Electronic Submission : 11 March 2005 Notification of acceptance/Rejection : 15 April 2005 Camera ready submission of full papers: 13 May 2005

1 0